Sign in

CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
300409740
Phone
(415) 651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 17 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-11-23 Graham G. Walmsley Director Conversion · Series B Convertible Preferred Stock −1,400,761 0
2020-11-23 Graham G. Walmsley Director Conversion · Series C Convertible Preferred Stock −1,183,114 0
2020-11-23 RAPPAPORT ANDREW Director Conversion +318,723 351,181
2020-11-23 RAPPAPORT ANDREW Director Conversion +129,833 481,014
2020-11-23 RAPPAPORT ANDREW Director Conversion · Series A Convertible Preferred Stock −318,723 0
2020-11-23 RAPPAPORT ANDREW Director Conversion · Series A-1 Convertible Preferred Stock −129,833 0
2020-11-23 Myles David C. Chief Development Officer Conversion +12,831 12,831
2020-11-23 Myles David C. Chief Development Officer Conversion +154,846 154,846
2020-11-23 Myles David C. Chief Development Officer Conversion · Series A Convertible Preferred Stock −12,831 0
2020-11-23 Myles David C. Chief Development Officer Conversion · Series A Convertible Preferred Stock −154,846 0
2020-11-23 MCCORMICK FRANK Director Conversion +152,891 191,113
2020-11-23 MCCORMICK FRANK Director Conversion +66,326 84,260
2020-11-23 MCCORMICK FRANK Director Conversion · Series A-1 Convertible Preferred Stock −152,891 0
2020-11-23 MCCORMICK FRANK Director Conversion · Series A Convertible Preferred Stock −66,326 0
2020-11-23 Kushner Peter J. Chief Scientific Officer Conversion +228,761 1,301,513
2020-11-23 Kushner Peter J. Chief Scientific Officer Conversion +130,159 1,431,672
2020-11-23 Kushner Peter J. Chief Scientific Officer Conversion · Series A Convertible Preferred Stock −228,761 0
2020-11-23 Kushner Peter J. Chief Scientific Officer Conversion · Series A-1 Convertible Preferred Stock −130,159 0
2020-11-23 Harmon Cyrus Chief Technology Officer Conversion +71,374 1,111,546
2020-11-23 Harmon Cyrus Chief Technology Officer Conversion +122,028 122,028

Page 20 of 21 · 402 trades